REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 1 year 2 months ago bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux receives U.S. FDA clearance for the new version of its molecular test, the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, targeting causes of gastroenteritis. The test detects 11 common bacteria, viruses, and parasites from one sample in about 1 hour, improving patient outcomes BioMérieux FDA Clearance Gastroenteritis BIOFIRE® FILMARRAY® Molecular Test
BRIEF published on 02/06/2025 at 11:25, 1 year 2 months ago Biomérieux: Monthly statement on voting rights and shares Share Capital Voting Rights BioMérieux Actions 2025
BRIEF published on 01/13/2025 at 07:20, 1 year 3 months ago BioMérieux to Present Strategic Plans at J.P. Morgan HealthCare Conference BioMérieux GO•28 Strategy J.P. Morgan Conference SpinChip Acquisition Diagnostics Growth
REGULATED PRESS RELEASE published on 01/13/2025 at 07:15, 1 year 3 months ago bioMérieux to present at the 43rd Annual J.P. Morgan HealthCare Conference bioMérieux will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2025, highlighting strategic plan and recent acquisitions Acquisition BioMérieux In Vitro Diagnostics Strategic Plan J.P. Morgan Healthcare Conference
BRIEF published on 01/13/2025 at 07:05, 1 year 3 months ago BioMérieux Expands Point of Care Offerings with Acquisition of SpinChip BioMérieux Point Of Care SpinChip Acquisition Immunoassay Platform Healthcare Diagnostics
REGULATED PRESS RELEASE published on 01/13/2025 at 07:00, 1 year 3 months ago bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip. The innovative diagnostics platform aims to revolutionize MI diagnosis and improve patient outcomes BioMérieux Diagnostics Point Of Care Immunoassay SpinChip
BRIEF published on 01/07/2025 at 15:12, 1 year 3 months ago BioMérieux liquidity contract review for the second half of 2024 Liquidity Contract Transactions BioMérieux Actions ODDO BHF
BRIEF published on 01/07/2025 at 12:36, 1 year 3 months ago Half-yearly report on the bioMérieux Liquidity Contract Liquidity Contract BioMérieux Half-yearly Report ODDO BHF Securities And Cash
BRIEF published on 01/07/2025 at 11:43, 1 year 3 months ago BioMérieux: Statement on Shares and Voting Rights Share Capital Voting Rights BioMérieux Actions December 2024
BRIEF published on 12/09/2024 at 07:06, 1 year 4 months ago BioMérieux's Diagnostic Test Receives FDA Clearance BioMérieux FDA Clearance Healthcare Innovation Diagnostics Tropical Fever
Published on 04/21/2026 at 09:05, 1 hour 13 minutes ago Battery X Metals Files International PCT Patent Application for Lithium-Ion Battery Rebalancing Technology, Providing a Pathway to Pursue Patent Protection in 150+ Countries for Technology Validated by a Leading Scientific Institution to Recover ~99% Capa
Published on 04/21/2026 at 05:30, 4 hours 48 minutes ago Battery X Metals Provides Update on Critical Battery Metals Exploration Initiatives and Portfolio Optimization Strategy
Published on 04/21/2026 at 01:05, 9 hours 13 minutes ago Boron One Holdings Inc. Announces Closing of Financing
Published on 04/21/2026 at 00:00, 10 hours 18 minutes ago LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Published on 04/21/2026 at 10:05, 12 minutes ago BrightCharger and Endrich sign licensing agreement to expand BrightZero® charging control to new components and products
Published on 04/21/2026 at 10:05, 12 minutes ago ION brings mandatory EU payee verification live at scale
Published on 04/21/2026 at 10:00, 18 minutes ago Karlsberg Brauerei gains further market share in the 2025 financial year
Published on 04/21/2026 at 09:30, 47 minutes ago Original-Research: PFISTERER Holding SE (von GBC AG): BUY
Published on 04/21/2026 at 07:00, 3 hours 18 minutes ago Thales reports its order intake and sales for the first quarter of 2026
Published on 04/20/2026 at 20:44, 13 hours 33 minutes ago ENGIE - Implementation of share buyback programme
Published on 04/20/2026 at 20:01, 14 hours 17 minutes ago TERACT - Approval by the AMF of the public buy out offer followed by a squeeze-out of TERACT shares